Dexcom Stock Soars on Earnings. Ozempic Isn't the Threat It Was Supposed to Be
The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products.
Source: marketwatch.com
Stay updated with breaking news from Courtesy Dexcom. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The maker of continuous glucose monitoring devices said there was no sign weight-loss drugs were hurting demand for its products.
Worries that new weight loss drugs will impact demand for continuous glucose monitoring devices have gone too far.